The activation of Rho ATPase by CD44 enhances the cytoskeletal transformation and invasion, while other pathways like PI3K-AKT and MAPK-Ras enhances tumor cell growth, survival, and invasion (Bourguignon, 2019). This evidence concerns the gene CD44 and neoplasm.